Browse 1,662 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
for
Solid Tumor
Location: Pittsburgh PA, Edgewood KY, Iowa City IA, Phoenix AZ
Sponsor: Oxford BioTherapeutics Ltd
Sex: All
Age: 18+
Code: NCT04064359
Phase 1, Recruiting
Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
for
Solid Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06563375
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls
for
Neoplasm
Location: Baltimore MD
Sponsor: Sinai Hospital of Baltimore
Sex: All
Age: 18+
Code: NCT02450175
Recruiting
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Location: Quebec, Toronto, Cleveland OH, West Valley City UT,
Sponsor: Recursion Pharmaceuticals Inc.
Sex: All
Age: 12+
Code: NCT06678659
Phase 1, Phase 2, Recruiting
Is Radiation-before-pathology a Feasible Approach in the Palliative Oncology Setting? A Pragmatic Clinical Trial
for
Cancer
Location: London
Sponsor: David Palma
Sex: All
Age: 18+
Code: NCT06156800
Recruiting
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma, Cancer
Location: Wilmington NC, Durham NC, Chapel Hill NC, Charlotte NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05145400
Phase 2, Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
for
Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer,
Location: New Haven CT, New York NY, The Bronx NY,
Sponsor: SillaJen, Inc.
Sex: All
Age: 18+
Code: NCT05768932
Phase 1, Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Synthekine
Sex: All
Age: 18+
Code: NCT05098132
Phase 1, Phase 2, Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: Fairhaven MA, Norwich CT, York PA, East Syracuse NY,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT06207032
Recruiting
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05039632
Phase 1, Phase 2, Recruiting
Immune Profiling for Cancer Immunotherapy Response
for
Cancer, Tumor, Solid, Hematologic Malignancy, Blood Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 18+
Code: NCT06116032
Recruiting
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
for
Solid Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06576037
Phase 1, Recruiting
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06015932
Recruiting
Combination Therapy in Cancers With Mutations in DNA Repair Genes
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies